Chemotherapy of advanced gastric cancer with 72-hour continuous intravenous 5-fluorouracil infusion at 2-week intervals

Twenty-nine patients with advanced gastric adenocarcinoma were treated with 72-hour continuous intravenous infusion of 5-fluorouracil (30 mg/kg/24 hr) at 2-week intervals. Six patients (21%) achieved partial response and four (14%) had stabilization of their disease. The median duration of partial r...

Full description

Saved in:
Bibliographic Details
Published in:Medical and pediatric oncology Vol. 11; no. 5; p. 358
Main Authors: Shah, A, MacDonald, W C
Format: Journal Article
Language:English
Published: United States 1983
Subjects:
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Twenty-nine patients with advanced gastric adenocarcinoma were treated with 72-hour continuous intravenous infusion of 5-fluorouracil (30 mg/kg/24 hr) at 2-week intervals. Six patients (21%) achieved partial response and four (14%) had stabilization of their disease. The median duration of partial response was 8 months, with a range of 5-19 months. The median survival time for all patients from the start of chemotherapy was 8 months. Various prognostic factors important in determining response and survival are analyzed.
AbstractList Twenty-nine patients with advanced gastric adenocarcinoma were treated with 72-hour continuous intravenous infusion of 5-fluorouracil (30 mg/kg/24 hr) at 2-week intervals. Six patients (21%) achieved partial response and four (14%) had stabilization of their disease. The median duration of partial response was 8 months, with a range of 5-19 months. The median survival time for all patients from the start of chemotherapy was 8 months. Various prognostic factors important in determining response and survival are analyzed.
Author MacDonald, W C
Shah, A
Author_xml – sequence: 1
  givenname: A
  surname: Shah
  fullname: Shah, A
– sequence: 2
  givenname: W C
  surname: MacDonald
  fullname: MacDonald, W C
BackLink https://www.ncbi.nlm.nih.gov/pubmed/6633428$$D View this record in MEDLINE/PubMed
BookMark eNotkDtPwzAAhD0UlbawsiH5D7j4GccjioAiVWKBuXL8IIbEjpykVf89qej03elON9waLGKKDoAHgrcEY_rU9WlLlcCEYEHYAqwwViUigtFbsB6GHzx7JcslWBYFY5yWK3CqGtelsXFZ92eYPNT2qKNxFn7rYczBQHOxGZ7C2EBJUZOmDE2KY4hTmgYY4pj10cWLFsi3U8pzQ5vQzpGfhpAi1COk6OTc76Xt8lG3wx248TPc_ZUb8PX68lnt0P7j7b163iPDsWRIcuk99VgJ7oUosNdaKCs8UbXglpWsUMY4zVVJKZfGmlJY6WrqiJe1NopuwOP_bj_VnbOHPodO5_PhegD9AxpOX64
CitedBy_id crossref_primary_10_1093_oxfordjournals_annonc_a057858
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1002/mpo.2950110513
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
ExternalDocumentID 6633428
Genre Journal Article
GroupedDBID .GA
.GJ
.Y3
10A
1L6
1OB
1OC
1ZS
31~
3WU
4ZD
51W
51X
52N
52O
52P
52R
52S
52T
52W
52X
53G
5GY
66C
7PT
8-1
8-4
8-5
930
A01
A03
AAEVG
AAHHS
AANLZ
AAXRX
AAZKR
ABCUV
ABIJN
ABJNI
ABPPZ
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACFBH
ACGFS
ACMXC
ACPOU
ACXBN
ACXQS
ADBTR
ADEOM
ADIZJ
ADMGS
ADOZA
AEEZP
AEIGN
AEIMD
AEQDE
AEUQT
AEUYR
AFBPY
AFFNX
AFFPM
AFGKR
AFPWT
AFZJQ
AHBTC
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZFZN
BDRZF
BRXPI
BY8
CGR
CO8
CS3
CUY
CVF
D-7
D-F
DCZOG
DRFUL
DRMAN
DRSTM
EBS
ECM
EIF
EJD
F00
F01
F04
F5P
FEDTE
G-S
GLUZI
GODZA
HBH
HGLYW
HHY
HHZ
HVGLF
JPC
KQQ
LATKE
LAW
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LYRES
M6P
MEWTI
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
NPM
P4B
P4D
PALCI
QB0
QRW
RIWAO
ROL
RWI
SAMSI
SUPJJ
UB1
W99
WIB
WIH
WIJ
WIK
WJL
WQJ
WRC
WUP
WWO
WXI
WXSBR
XG1
XPP
XV2
ZGI
ZXP
ID FETCH-LOGICAL-c4073-747ff2f0954f5560faa59d5f19b54d38369ccea4982247cdc85d7eb2e1f7bac92
ISSN 0098-1532
IngestDate Sat Sep 28 08:40:34 EDT 2024
IsPeerReviewed false
IsScholarly false
Issue 5
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c4073-747ff2f0954f5560faa59d5f19b54d38369ccea4982247cdc85d7eb2e1f7bac92
PMID 6633428
ParticipantIDs pubmed_primary_6633428
PublicationCentury 1900
PublicationDate 1983-00-00
PublicationDateYYYYMMDD 1983-01-01
PublicationDate_xml – year: 1983
  text: 1983-00-00
PublicationDecade 1980
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Medical and pediatric oncology
PublicationTitleAlternate Med Pediatr Oncol
PublicationYear 1983
SSID ssj0009978
Score 1.1939124
Snippet Twenty-nine patients with advanced gastric adenocarcinoma were treated with 72-hour continuous intravenous infusion of 5-fluorouracil (30 mg/kg/24 hr) at...
SourceID pubmed
SourceType Index Database
StartPage 358
SubjectTerms Adenocarcinoma - diagnosis
Adenocarcinoma - drug therapy
Adenocarcinoma - mortality
Adult
Aged
Drug Administration Schedule
Female
Fluorouracil - administration & dosage
Humans
Infusions, Parenteral
Male
Middle Aged
Stomach Neoplasms - diagnosis
Stomach Neoplasms - drug therapy
Stomach Neoplasms - mortality
Title Chemotherapy of advanced gastric cancer with 72-hour continuous intravenous 5-fluorouracil infusion at 2-week intervals
URI https://www.ncbi.nlm.nih.gov/pubmed/6633428
Volume 11
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NT9swFLfaTZu4TOwDAWOTD7shb40_SHycSicu5QIT3JA_abU1qVpKxX_Pc-zQhGkaO3CJIjuy4vx-ennv-flnhL4YwzjnihE20JzwXHuiKBOEaz3gKrPSm_oQ27P89LI4HvFRr9ekBjZtz4o0tAHWYefsf6D9MCg0wD1gDldAHa5Pwj0oAKRdVXedRf5rFY7oMKHMy7hFTMDmlExg0LpgfVquQjnsNGR7b6NyqyD-96pawBPKTIM4h18t6_Llm0NK1s79qtUmFvD6y7aT2yz-1BoEzVEgh1VpOin8s4madJKpY9XKVF-k9K2NO_QK1kpIJCMrITAVrGtksxaZRMtisqjc_oclj8qws3n1lUoRnBQR96y2IJzPagzBZ2KcFv_sfKSrnXr6qA9OUvCjh-ONWrNMv_A0k0btc0C_dd9oC71K4zwKS2r35HwbvUlxBf4eCfEW9Vz5Dr0ep8qJ92jd5gWuPG54gRMvcOQFDrzAiRd4wwvc4gXu8gI3vMDqBkde4AdefEA_f4zOhyckHbpBDMT2jEB46T314HlzL8Ad9koJaYXPpBbcsoIdSWOc4kH3kefGmkLY3GnqMp9rZSTdQS_KqnS7COfOCke9zDQYhIHMVVFwaTlThc5gRL-HduInu5pHZZWr9C33_9bxEW1tGHeAXnqYh_uE-ku7-lwjeA8pDmVM
link.rule.ids 782
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Chemotherapy+of+advanced+gastric+cancer+with+72-hour+continuous+intravenous+5-fluorouracil+infusion+at+2-week+intervals&rft.jtitle=Medical+and+pediatric+oncology&rft.au=Shah%2C+A&rft.au=MacDonald%2C+W+C&rft.date=1983-01-01&rft.issn=0098-1532&rft.volume=11&rft.issue=5&rft.spage=358&rft_id=info:doi/10.1002%2Fmpo.2950110513&rft_id=info%3Apmid%2F6633428&rft_id=info%3Apmid%2F6633428&rft.externalDocID=6633428
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0098-1532&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0098-1532&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0098-1532&client=summon